BioXcel Therapeutics (BTAI) Short Interest Ratio & Short Volume $0.59 -0.01 (-1.67%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BioXcel Therapeutics Short Interest DataBioXcel Therapeutics (BTAI) has a short interest of 347,100 shares. This marks a -39.78% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 822,184 shares to cover all short positions.Current Short Interest347,100 sharesPrevious Short Interest576,400 sharesChange Vs. Previous Month-39.78%Dollar Volume Sold Short$231,446.28Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares42,750,000 sharesPercentage of Shares Shorted0.81%Today's Trading Volume372,885 sharesAverage Trading Volume822,184 sharesToday's Volume Vs. Average45% Short Selling BioXcel Therapeutics? Sign up to receive the latest short interest report for BioXcel Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBTAI Short Interest Over TimeBTAI Days to Cover Over TimeBTAI Percentage of Float Shorted Over Time Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin BioXcel Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024347,100 shares $231,446.28 -39.8%N/A0.7 $0.67 10/15/2024576,400 shares $327,913.96 +11.6%N/A1.2 $0.57 9/30/2024516,400 shares $315,004.00 -26.0%N/A0.9 $0.61 9/15/2024697,600 shares $474,368.00 +2.5%N/A1.1 $0.68 8/31/2024680,500 shares $418,507.50 -6.9%N/A1.2 $0.62 8/15/2024731,200 shares $497,216.00 -9.4%N/A1.2 $0.68 Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024807,300 shares $904,176.00 +28.9%N/A1.2 $1.12 7/15/2024626,100 shares $763,842.00 -61.4%N/A1 $1.22 6/30/20241,620,000 shares $2.07 million +8.7%N/A2.8 $1.28 6/15/20241,490,000 shares $2.04 million +0.7%N/A2.9 $1.37 5/31/20241,480,000 shares $2.68 million -9.2%N/A2.6 $1.81 5/15/20241,630,000 shares $3.36 million +8.7%N/A2.8 $2.06 4/30/20241,500,000 shares $3.78 million -28.2%N/A1 $2.52 4/15/20242,090,000 shares $5.75 million -16.1%N/A1.4 $2.75 3/31/20242,490,000 shares $7.02 million -20.7%10.5%1.7 $2.82 3/15/20243,140,000 shares $8.42 million -20.9%14.6%2.1 $2.68 2/29/20243,970,000 shares $12.62 million -46.8%18.7%2.6 $3.18 2/15/20247,460,000 shares $26.78 million +203.3%35.2%4.9 $3.59 1/31/20242,460,000 shares $7.92 million -17.5%11.9%2.1 $3.22 1/15/20242,980,000 shares $7.84 million +0.3%14.4%1.1 $2.63 12/31/20232,970,000 shares $8.76 million +3.5%14.7%1 $2.95 12/15/20232,870,000 shares $9.30 million -16.6%14.2%0.9 $3.24 11/30/20233,440,000 shares $13.07 million -32.3%17.0%1.1 $3.80 11/15/20235,080,000 shares $22.35 million -12.6%25.1%1.6 $4.40 10/31/20235,810,000 shares $23.33 million +16.9%28.8%1.9 $4.02 10/15/20234,970,000 shares $15.56 million +38.8%24.6%3.6 $3.13 9/30/20233,580,000 shares $9.06 million -24.6%17.7%2.4 $2.53 9/15/20234,750,000 shares $15.87 million +8.0%23.5%1.6 $3.34 8/31/20234,400,000 shares $16.63 million -34.8%21.8%1.5 $3.78 8/15/20236,750,000 shares $27.95 million -4.1%33.5%2.3 $4.14 7/31/20237,040,000 shares $64.35 million -18.8%35.0%2.7 $9.14 7/15/20238,670,000 shares $89.30 million +69.0%43.1%3.5 $10.30 6/30/20235,130,000 shares $34.17 million +12.3%25.5%2.2 $6.66 6/15/20234,570,000 shares $98.26 million +22.9%22.7%8.3 $21.50 5/31/20233,720,000 shares $66.74 million +11.0%18.5%6.2 $17.94 5/15/20233,350,000 shares $91.22 million -5.4%16.7%6.5 $27.23 4/30/20233,540,000 shares $72.99 million -5.1%17.7%6.9 $20.62 4/15/20233,730,000 shares $69.90 million +3.6%18.6%7.4 $18.74 3/31/20233,600,000 shares $67.18 million +21.2%18.3%7.2 $18.66 3/15/20232,970,000 shares $58.21 million +5.7%15.1%6.3 $19.60Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 2/28/20232,810,000 shares $89.70 million +8.9%14.7%8 $31.92 2/15/20232,580,000 shares $84.29 million +5.3%13.5%7.6 $32.67 1/31/20232,450,000 shares $69.87 million +5.6%12.9%7.4 $28.52 1/15/20232,320,000 shares $67.14 million -3.3%12.2%8.1 $28.94 12/30/20222,400,000 shares $51.55 million +10.1%12.6%9.4 $21.48 12/15/20222,180,000 shares $44.04 million -4.4%11.5%9 $20.20 11/30/20222,280,000 shares $37.78 million -3.4%12.0%10.2 $16.57 11/15/20222,360,000 shares $38.00 million -6.7%12.4%10.9 $16.10 10/31/20222,530,000 shares $31.85 million -4.2%13.3%11.7 $12.59 10/15/20222,640,000 shares $27.06 million -5.7%13.9%11.1 $10.25 9/30/20222,800,000 shares $33.10 million -2.1%14.7%10.4 $11.82 9/15/20222,860,000 shares $37.95 million -2.4%15.0%8.5 $13.27 8/31/20222,930,000 shares $40.08 million -0.3%15.4%6.9 $13.68 8/15/20222,940,000 shares $44.86 million +7.7%15.5%6.1 $15.26 7/31/20222,730,000 shares $42.15 million -5.5%14.4%5 $15.44 7/15/20222,890,000 shares $48.70 million -19.7%15.2%5 $16.85 6/30/20223,600,000 shares $47.52 million -9.3%19.0%4 $13.20 6/15/20223,970,000 shares $39.14 million -1.2%20.9%4.4 $9.86 5/31/20224,020,000 shares $47.03 million -2.9%21.2%4.8 $11.70 5/15/20224,140,000 shares $48.60 million +5.3%21.8%5.2 $11.74 4/30/20223,930,000 shares $51.52 million -3.0%20.7%5.3 $13.11 4/15/20224,050,000 shares $63.10 million +97.6%21.4%5.7 $15.58 3/31/20222,050,000 shares $42.87 million +9.0%10.8%3.3 $20.91 3/15/20221,880,000 shares $28.31 million +0.5%9.9%6.1 $15.06 2/28/20221,870,000 shares $34.24 million +10.7%9.9%6.5 $18.31 2/15/20221,690,000 shares $31.38 million -5.1%8.9%5.4 $18.57 1/31/20221,780,000 shares $30.08 million -0.6%9.4%5.5 $16.90 1/15/20221,790,000 shares $34.91 million +3.5%9.4%5.9 $19.50 12/31/20211,730,000 shares $35.17 million -11.7%9.1%5.7 $20.33 12/15/20211,960,000 shares $42.59 million -1.0%10.3%6.7 $21.73 11/30/20211,980,000 shares $45.40 million +10.6%10.4%6.9 $22.93 11/15/20211,790,000 shares $48.71 million -4.3%9.4%6.6 $27.21 10/29/20211,870,000 shares $54.49 million +8.1%9.9%7.5 $29.14 10/15/20211,730,000 shares $46.87 million -6.0%9.1%6.7 $27.09 9/30/20211,840,000 shares $55.84 million -3.2%9.7%6.9 $30.35 9/15/20211,900,000 shares $56.51 million -6.9%10.0%5.4 $29.74 8/31/20212,040,000 shares $60.08 million -8.1%10.8%5.4 $29.45 8/13/20212,220,000 shares $54.59 million -5.9%11.8%5.9 $24.59 7/30/20212,360,000 shares $60.39 million -9.9%12.6%6.1 $25.59 7/15/20212,620,000 shares $70.11 million -11.8%14.0%6.8 $26.76 6/30/20212,970,000 shares $86.31 million +2.1%16.9%7.7 $29.06 6/15/20212,910,000 shares $108.60 million -5.5%19.2%7.8 $37.32 5/28/20213,080,000 shares $101.73 million -3.1%20.3%7.8 $33.03 5/14/20213,180,000 shares $96.67 million -5.6%21.0%7.3 $30.40 4/30/20213,370,000 shares $116.27 million -7.7%22.3%7.1 $34.50 4/15/20213,650,000 shares $127.57 million +9.0%N/A7 $34.95 3/31/20213,350,000 shares $137.69 million -9.7%21.4%6.1 $41.10 3/15/20213,710,000 shares $174.33 million +2.8%23.8%6.5 $46.99 2/26/20213,610,000 shares $199.09 million +1.1%23.4%6.7 $55.15 2/12/20213,570,000 shares $230.62 million +5.6%23.1%6.8 $64.60Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 1/29/20213,380,000 shares $156.33 million -7.9%23.0%6.6 $46.25 1/15/20213,670,000 shares $198.55 million +10.2%25.0%7.7 $54.10 12/31/20203,330,000 shares $163.90 million +4.4%22.7%6.9 $49.22 12/15/20203,190,000 shares $147.89 million -2.5%21.8%7.2 $46.36 11/30/20203,270,000 shares $145.81 million +10.9%22.3%7.2 $44.59 11/15/20202,950,000 shares $160.13 million +4.2%20.1%6.2 $54.28 10/30/20202,830,000 shares $133.15 million +22.0%22.4%5.2 $47.05 10/15/20202,320,000 shares $120.41 million -13.8%18.3%3.5 $51.90 9/30/20202,690,000 shares $116.64 million +17.0%21.3%3.9 $43.36 9/15/20202,300,000 shares $111.09 million +6.5%18.2%3.3 $48.30 8/31/20202,160,000 shares $88.02 million -10.4%17.1%3.1 $40.75 8/14/20202,410,000 shares $90.42 million -14.2%20.7%3.5 $37.52 7/31/20202,810,000 shares $127.46 million +30.1%22.3%4.6 $45.36 7/15/20202,160,000 shares $109.08 million -3.6%20.6%4.3 $50.50 6/30/20202,240,000 shares $118.74 million +137.3%21.3%4.8 $53.01 6/15/2020944,000 shares $44.91 million +39.9%9.0%2.1 $47.57 5/29/2020674,800 shares $31.42 million -13.6%6.4%1.4 $46.56 5/15/2020781,000 shares $36.83 million -8.4%7.4%1.4 $47.16 4/30/2020852,400 shares $31.54 million +30.0%8.1%1.2 $37.00 4/15/2020655,500 shares $15.68 million +8.4%6.3%1 $23.92 3/31/2020604,900 shares $18.67 million -21.2%5.9%0.9 $30.87 3/13/2020767,800 shares $17.83 million +57.6%7.5%1 $23.22 2/28/2020487,300 shares $8.64 million +15.5%4.8%0.9 $17.74 2/14/2020421,800 shares $13.40 million -4.7%4.7%0.9 $31.78 1/31/2020442,500 shares $14.37 million -3.2%5.4%1.7 $32.48 1/15/2020457,000 shares $9.81 million -23.2%5.6%2 $21.46 12/31/2019595,200 shares $10.41 million +2.3%7.3%2.8 $17.49 BTAI Short Interest - Frequently Asked Questions What is BioXcel Therapeutics' current short interest? Short interest is the volume of BioXcel Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 347,100 shares of BTAI short. Learn More on BioXcel Therapeutics' current short interest. What is a good short interest ratio for BioXcel Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BTAI shares currently have a short interest ratio of 1.0. Learn More on BioXcel Therapeutics's short interest ratio. Is BioXcel Therapeutics' short interest increasing or decreasing? BioXcel Therapeutics saw a drop in short interest in October. As of October 31st, there was short interest totaling 347,100 shares, a drop of 39.8% from the previous total of 576,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioXcel Therapeutics' short interest compare to its competitors? Here is how the short interest of companies compare to BioXcel Therapeutics: Monopar Therapeutics Inc. (3.58%), Milestone Pharmaceuticals Inc. (0.85%), Eupraxia Pharmaceuticals Inc. (0.39%), Anixa Biosciences, Inc. (1.38%), Nuvectis Pharma, Inc. (13.65%), Karyopharm Therapeutics Inc. (14.12%), Eliem Therapeutics, Inc. (2.22%), Immunic, Inc. (5.00%), MediciNova, Inc. (0.39%), Adagene Inc. (0.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short BioXcel Therapeutics stock? Short selling BTAI is an investing strategy that aims to generate trading profit from BioXcel Therapeutics as its price is falling. BTAI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioXcel Therapeutics? A short squeeze for BioXcel Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BTAI, which in turn drives the price of the stock up even further. How often is BioXcel Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BTAI, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies MNPR Short Squeeze NVCT Short Squeeze MIST Short Squeeze EPRX Short Squeeze ANIX Short Squeeze KPTI Short Squeeze ELYM Short Squeeze CHRS Short Squeeze IMUX Short Squeeze MNOV Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BTAI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
